Issue 2/2016
Content (19 Articles)
Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis
Qiufan Zheng, Wen Xia, Qianyi Lu, Ruoxi Hong, Ge Qin, Fei Xu, Tao Qin, Yanxia Shi, Zhongyu Yuan, Shusen Wang
The 2016 Assisi Think Tank Meeting on breast cancer: white paper
Cynthia Aristei, Orit Kaidar-Person, Meritxell Arenas, Charlotte Coles, Birgitte V. Offersen, Celine Bourgier, Giovanni Frezza, Maria Cristina Leonardi, Vincenzo Valentini, Philip M. P. Poortmans
Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysis
Jill Brook Hervik, Trine Stub
High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome
Satu Tiainen, Sanna Oikari, Markku Tammi, Kirsi Rilla, Kirsi Hämäläinen, Raija Tammi, Veli-Matti Kosma, Päivi Auvinen
A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
Nathalie Reix, Charlotte Malina, Marie-Pierre Chenard, Jean-Pierre Bellocq, Stéphanie Delpous, Sébastien Molière, Anthony Sevrin, Karl Neuberger, Catherine Tomasetto, Carole Mathelin
Treatment with aromatase inhibitors and markers of cardiovascular disease
Eva Blondeaux, Debora Musio, Paolo Bruzzi, Matteo Lambertini, Valerio Gazzola, Francesca Poggio, Stefania Vecchio, Alessia Levaggi, Alessia D’Alonzo, Maria Cecilia Perfumo, Claudia Bighin, Sara Giraudi, Domenico Palombo, Lucia Del Mastro
Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience
Eun Joo Yang, Soyeon Ahn, Eun-Kyu Kim, Eunyoung Kang, Youngmi Park, Jae-Young Lim, Sung-Won Kim
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer
Thomas M. Deutsch, Sabine Riethdorf, Juliane Nees, Andreas D. Hartkopf, Birgitt Schönfisch, Christoph Domschke, Martin R. Sprick, Florian Schütz, Sara Y. Brucker, Stefan Stefanovic, Christof Sohn, Klaus Pantel, Andreas Trumpp, Andreas Schneeweiss, Markus Wallwiener
Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins
YaoYao G. Pollock, Amanda L. Blackford, Stacie C. Jeter, Jean Wright, Ashley Cimino-Mathews, Melissa Camp, Susan Harvey, Fariba Asrari, Nancy L. Schoenborn, Vered Stearns
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)
Mehra Golshan, Constance T. Cirrincione, William M. Sikov, Lisa A. Carey, Donald A. Berry, Beth Overmoyer, Nora L. Henry, George Somlo, Elisa Port, Harold J. Burstein, Clifford Hudis, Eric Winer, David W. Ollila
Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study
Sara M. Tolaney, Hovav Nechushtan, Ilan-Gil Ron, Patrick Schöffski, Ahmad Awada, Chris A. Yasenchak, A. Douglas Laird, Bridget O’Keeffe, Geoffrey I. Shapiro, Eric P. Winer
Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer
Anna Nordenskjöld, Helena Fohlin, Tommy Fornander, Britta Löfdahl, Lambert Skoog, Olle Stål
Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium
Elisabeth F. Beaber, Anna N. A. Tosteson, Jennifer S. Haas, Tracy Onega, Brian L. Sprague, Donald L. Weaver, Anne Marie McCarthy, Chyke A. Doubeni, Virginia P. Quinn, Celette Sugg Skinner, Ann G. Zauber, William E. Barlow
Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988–2013
Allison W. Kurian, Alison J. Canchola, Scarlett L. Gomez, Christina A. Clarke
Prognostic models in male breast cancer
Carmen C. van der Pol, Miangela M. Lacle, Arjen J. Witkamp, Robert Kornegoor, Hui Miao, Christine Bouchardy, Inne Borel Rinkes, Elsken van der Wall, Helena M. Verkooijen, Paul J. van Diest
The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis
Emily K. Hartman, Guy D. Eslick
The association between China’s Great famine and risk of breast cancer according to hormone receptor status: a hospital-based study
Aliya Alimujiang, Miao Mo, Ying Liu, Nai-si Huang, Guangyu Liu, Wanghong Xu, Jiong Wu, Zhen-zhou Shen, Zhimin Shao, Graham A Colditz
Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients
Zibo Li, Jianfu Heng, Jinhua Yan, Xinwu Guo, Lili Tang, Ming Chen, Limin Peng, Yepeng Wu, Shouman Wang, Zhi Xiao, Zhongping Deng, Lizhong Dai, Jun Wang
Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer
Christine Leopold, Anita K. Wagner, Fang Zhang, Christine Y. Lu, Craig Earle, Larissa Nekhlyudov, Dennis Ross-Degnan, J. Frank Wharam